Medical Malpractice Risk Management and Informed Consent in Dermatology and Dermatopathology

Conclusions

• Dermatology and dermatopathology are relatively low-risk specialties for malpractice compared with many other fields, but melanoma and skin-cancer misdiagnosis remain major sources of liability.
• A small subset of physicians appears to account for a disproportionately large share of paid malpractice claims, which may reflect either riskier practice patterns or other underlying factors.
• Many patients harmed by medical error never file suit, and litigation risk depends not only on the mistake itself but also on the patient relationship and how the error is handled.
• Good communication, spending a little more time with patients, using humor appropriately, and building rapport can reduce the likelihood of malpractice claims.
• Informed consent is both an ethical duty and a legal protection, and its value extends beyond the signed form to creating shared understanding of risks, benefits, and alternatives.
• Reasonable, prudent disclosure of risks and careful documentation are important, especially for common “low-hanging fruit” issues like pregnancy status, allergies, medication side effects, and procedure complications.
• Medical errors should be disclosed honestly, because disclosure is ethically required and can also affect legal timelines and patient trust.
• Apology laws vary widely by state, so what can be safely said after an adverse event depends on local law.
• Clear communication, timely follow-up, and proactive review of uncertain cases are practical steps that can improve safety and reduce medicolegal exposure.
• When sued, clinicians should respond strategically through insurers, risk management, and counsel, while avoiding record tampering, inappropriate contact, and other actions that can worsen liability.